Ramius Overview

  • Year Founded
  • 1918

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 64

Ramius General Information

Description

Operator of investment firm. The company is engaged in offering a broad range of alternative investment vehicles through three different investment programs: hedge funds including multi-strategy and single strategy and fund of funds.

Contact Information

Website
www.ramius.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 599 Lexington Avenue
  • 19th Floor
  • New York, NY 10022
  • United States
Primary Industry
Investment Banks
Other Industries
Other Capital Markets/Institutions
Acquirer
Corporate Office
  • 599 Lexington Avenue
  • 19th Floor
  • New York, NY 10022
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ramius Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ramius‘s full profile, request access.

Request a free trial

Ramius Investments & Acquisitions (64)

Ramius’s most recent deal was a Early Stage VC with Aeglea BioTherapeutics for . The deal was made on 23-Mar-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aeglea BioTherapeutics 23-Mar-2015 Early Stage VC Drug Discovery
Blueprint Medicines 12-Nov-2014 Later Stage VC Drug Discovery
Beetel Teletech 15-Jul-2014 Buyout/LBO Connectivity Products
proFair 09-Nov-2012 Buyout/LBO Leisure Facilities
Mobile Phone Xchange 24-Sep-2012 Buyout/LBO Other Communications and Networking
You’re viewing 5 of 64 investments and acquisitions. Get the full list »

Ramius Exits (50)

Ramius’s most recent exit was on 23-Mar-2015 from Aeglea BioTherapeutics. The exit was categorized as with 14 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Aeglea BioTherapeutics 23-Mar-2015 Completed
  • 14 buyers
Blueprint Medicines 12-Nov-2014 Completed
  • 18 buyers
Genetix Biotherapeutics 25-Jul-2012 Completed
  • 7 buyers
Cypress Bioscience 15-Dec-2010 Completed
  • 2 buyers
Sinohub 24-Feb-2010 PIPE Completed
  • 10 buyers
You’re viewing 5 of 50 exits. Get the full list »

Ramius FAQs

  • When was Ramius founded?

    Ramius was founded in 1918.

  • Where is Ramius headquartered?

    Ramius is headquartered in New York, NY.

  • What industry is Ramius in?

    Ramius’s primary industry is Investment Banks.

  • Is Ramius a private or public company?

    Ramius is a Private company.

  • What is Ramius’s current revenue?

    The current revenue for Ramius is .

  • When was Ramius acquired?

    Ramius was acquired on 02-Nov-2009.

  • Who acquired Ramius?

    Ramius was acquired by TD Cowen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process